Fibroadenosis also known as fi brocystic breast disease constitutes the most frequent benign disorder of the breast causing constant breast pain. The only known treatment in conventional medicine is anti-infl ammatory medicines which give temporary relief or surgical excision which results in scarring of breast tissue. The homoeopathic literature shows that cases related to breast lump, mastitis, etc. have been treated successfully; however, no case study/research trial has been documented till date in any peer-reviewed journal. The case reported here is of fi broadenosis in 31-year-old female who was treated successfully with individualised homoeopathic medicine within 6 months with no recurrence. Phytolacca was prescribed as a constitutional remedy on the basis of totality of symptoms and after repertorisation. Investigatory procedures such as mammography and ultrasonography were done before and after to record resolution of cysts. The patient has been observed for more than 1 year without recurrence which can be considered as near permanent cure through individualised homoeopathic treatment. Resolution of cysts in this case of fi broadenosis with Homoeopathy can be considered a lead to explore the utility of alternative modes of treatment such as Homoeopathy to give a better therapeutic option for such surgical conditions.
INTRODUCTION
Fibroadenosis also known as fi brocystic breast disease is a common benign breast disease characterised by varying degree of fibrocystic changes in the breast tissue. The fi brocystic breast has a dense irregular and lumpy consistency. The most common presenting symptoms are breast pain, tender nodularities which are round and moveable in breasts and sensitive nipples. These symptoms may change throughout the menstrual cycle that is increase in size of the cyst and tenderness before menstrual cycle and usually stop after menopause. [1, 2] Such changes generally affect women of reproductive age group between 20 and 50 years of age. It may be multifocal and bilateral. [3] Types of fi brocystic breast disease are: [2] • Fibrosis -this is fi brous tissue similar to scar tissue. It feels rubbery, fi rm or hard to touch • Cysts -These are fl uid-fi lled sacs. Microscopic cysts are too small to feel. These may get bigger and form macrocysts, which may be 2.5-5 cm (1-2 inch) across.
As per records, fibroadenosis is known to be affecting an estimated 30%-60% of women. Although the exact pathogenesis of the entity is not clear, hormonal imbalance, particularly estrogen predominance over progesterone, seems to play an important role in its development. Fibrocystic changes comprise both cysts (macro and micro) and solid lesions, including adenosis, epithelial hyperplasia with or without atypia, apocrine metaplasia, radial scar and papilloma. [3] Treatment There is no defi nite treatment available for fi broadenosis. Removing fl uid through fi ne-needle aspiration may help relieve symptoms of pain or pressure. However, the fl uid may return later. In most of the cases, over-the-counter pain relievers such as non-steroidal anti-infl ammatory medicines are given to temporarily relieve the pain. [2] Alternatively, surgery is advised in cases of constant recurrence of pain in spite of pain relievers. However, scarring of breast tissue and recurrence of disease after surgery are the prime cause due to which patients opt for alternative treatments.
Diagnosis
Mammography and ultrasonography (USG) are done to evaluate a mass in a patient with fibrocystic condition. Mammography is usually the fi rst imaging test to be done in women above 35 years of age when unusual breast changes are detected during a physical examination. USG alone may be used in women under 30 years of age. [4] Ultrasound breasts are commonly performed in conjunction with mammography for confi rmation as they produce clear images of the breast and helps distinguish between fl uid-fi lled breast cysts and solid masses.
Prognosis
As per conventional treatment, pain, tenderness and cyst formation may occur at any time until the menopause, when symptoms usually subside, except in patients receiving hormonal replacement therapy. [4] 
CASE REPORT
A 31-year-old married female presented in outpatient department (OPD) of Dr. D.P. Rastogi Central Research Institute of Homoeopathy, Noida, with complaint of burning pain in the breasts for 4-5 months which aggravated on touch, pressure and before menses. Pain was occasionally burning in character. Ultrasound breasts [ Figure 1 ] and mammography [ Figure 2 ] revealed fi broadenosis in both breasts. She had been advised anti-infl ammatory and pain killer medicines in case of acute pain, which gave her temporary relief and was asked to opt for surgery. However, the patient did not want to go for surgery with fear of scarring and recurrence in the future. Thus, she opted for homoeopathic treatment. Fine-needle aspiration cytology was also advised; however, the patient was not willing to go for any invasive test.
On examination, cystic swellings were felt in periareolar region of both breasts.
Apart from the main presenting complaints, she also reported about pain in both knee joints for 1 month which was aggravated on continuous walking. Thermal reaction was chilly and there was aversion to sour/acidic food. Thirst for small quantities of water at shorter intervals was present.
Following symptoms were considered for repertorisation:
• Fibrocystic tumours • Pain in breasts on touch • Pain in breasts before menses Repertorisation was done using RADAR 10 software [5] (Synthesis repertory 9.0 version), Archibel Homoeopathic software. Repertorial result is shown in Table 1 .
Intervention
First prescription (2 September 2015) Phytolacca 30/tds/1 week followed by Placebo 30/tds/1 week.
Basis of prescription
Medicine selected as per repertorisation and in consultation with Homoeopathic Materia Medica was Phytolacca. Furthermore, fi brocystic disease, pain aggravation on touch and burning pains which were predominant symptoms were covered by Phytolacca; therefore, Phytolacca was prescribed. In this case, as there was acute pain and tenderness. Therefore, medicine was prescribed in 30C thrice a day for a week. In subsequent follow-ups, potency was changed based on assessment of symptom/sign improvement as mentioned in Table 2 .
Follow-up
Follow-up of patient was assessed fortnightly or earlier as per the requirement. The patient adhered to the medical intervention even after initial aggravation of symptoms after raising the potency from 30C to 200C.
On examination on 7 November 2015, the cystic swellings in subareolar region were found with mild tenderness. Thus, the potency was changed from centesimal to 50 Millesimal (LM) which brought overall improvement. USG was repeated after 6 months of treatment which showed complete resolution of fi broadenosis [ Figure 3 ]. Patient was prescribed SL 30 three times a day for 6 months as there was complete disappearance of symptoms.
Details of follow-ups are given in Table 2 .
RESULTS
Patient improved symptomatically gradually after prescription of Phytolacca in 50 Millesimal (LM) potencies. There was a signifi cant reduction in pain along with cystic swellings which resolved completely over 6 months duration. Ultrasound breasts done after 6 months at Dr. D.P. Rastogi Figure 3 ] showed normal study with complete resolution of fi broadenosis 10/03/2016
There was no pain in breast and knee joints for the last 2 months SL 30/tds/1 month Relief in symptoms and no signs present, so SL was prescribed USG breasts [ Figure 4 ] done outside reconfi rmed normal scan with complete disappearance of fi brocystic changes 15/04/2016
There was no recurrence of symptoms; so patient was advised to report in OPD at 1-3 months interval SL 30/tds/2 months There was no recurrence of symptoms; so SL was prescribed 20/06/2016
There was no recurrence of symptoms SL 30/tds/2 months There was no recurrence of symptoms; so SL was prescribed 25/08/2016
No recurrence has been reported in the last 5-6 months interval. Patient was advised to report in case of any recurrence of symptoms SL 30/tds/2 months There was no recurrence of symptoms; so SL was prescribed USG: Ultrasonography; OPD: Outpatient department; LM: 50 Millisemal; SL: Sac lac-blank pills Central Research Institute of Homoeopathy, Noida, revealed normal study with complete resolution of cysts. Ultrasound was repeated after 1 month again from another laboratory to confi rm the fi ndings which also revealed normal scan [ Figure 4 ].
DISCUSSION
It has been well known that conventional treatment can help relieve the complaints associated with fi broadenosis and there are chances of recurrence, scarring, etc.whereas in this case treated with individualised homoeopathic medicine has not only brought relief in the signs and symptoms but also no recurrence has been reported in 1-year duration of follow-up.
Phytolacca is frequently used and supposed to be a specifi c remedy for glands, especially mammary glands. [6] As seen clinically, Phytolacca is useful in majority of cases presenting with mastitis, breast tumours, abscesses and even cancer of breast. However, in this case, after case history recording, repertorisation and consultation with Materia Medica, Phytolacca was prescribed on the basis of individualisation and totality of the symptoms and not just as a specifi c remedy. As a result, there was complete recovery in breast pain along with resolution of cysts. Apart from the presenting complaints of pain in breasts, associated symptoms such as pain in both knee joints also improved as medicine was given on constitutional basis. Thus, this case record refl ects that any constitutional remedy having specific organ affinity will surely bring complete recovery and at a faster pace.
The patient showed improvement in beginning which proved correct selection of medicine, but there was aggravation of symptoms after raising the potency. The acuteness of pain in breasts required repetition of medicine but in much milder dosage. Thus, LM potency was chosen in accordance to the directions of Dr. Hahnemann in the 6 th edition of Organon. 'Thus, in chronic diseases, every correctly chosen homoeopathic medicine, even those whose action is of long duration, may be repeated daily for months with ever increasing success'. [7] The patient showed marked improvement in symptoms when medicine was repeated frequently in LM potency. After 3 months of treatment with LM potency, there was complete amelioration in symptoms. This shows the importance of dose and repetition in achieving complete cure. USG was done after 6 months showed normal scan with complete resolution of cysts. This clearly shows homoeopathic approach with proper selection of medicine, potency and repetition of dosage is more scientifi c with promising results as compared to conventional medicine.
CONCLUSION
Homoeopathy is a specialised system of medicine which treats the patient as a whole and not just the disease. Non-recurrence of complaints for 1 year and disappearance of fi broadenosis on USG within 6 months are a documentary evidence of complete resolution with Homoeopathy in the light of modern medicine. 
Informe de un caso de fi broadenosis aliviada con homeopatía

Resumen
La fi broadenosis, también conocida como Enfermedad fi broquística dela mama, constituye el trastorno benigno más frecuente de la mama que causa un dolor mamario constante. El único tratamiento conocido en medicinaconvencional son los antiinfl amatorios que procuran un alivio transitorio, o la escisión quirúrgica que da lugar a la formación de cicatrices en el tejido mamario. En la bibliografía homeopática, se presentan casos relacionados con formaciones mamarias, mastitis, etc. que se han tratado con éxito. No obstante, hasta la fecha no se ha documentado ningún ensayo de investigación o estudio de casos en ninguna revista revisada por pares. El caso clínico referido en este artículo es una fi broadenosisen una mujer de 31 años de edad que fue tratada satisfactoriamente con un medicamentos homeopático individualizado en 6 meses sin presentar recurrencias. Se prescribió Phytolaccacomo remedio constitucional a partir de la totalidad de los síntomas y de la repertorización. Se efectuaron mamografías y ecografías antes y después del tratamiento para registrar la resolución de los quistes. El seguimiento de la paciente abarca más de un año sin recurrencias, lo que puede considerarse como curación casi permanente gracias al tratamiento homeopático individualizado. Este caso ilustra que la homeopatía puede ser una mejor opción terapéutica para tales condiciones quirúrgicas.
Un rapport de cas de fi broadénose atténué avec l'homéopathie
Résumé
La fi broadénose également connue sous le nom de maladie fi brokystique du sein constitue le trouble bénin le plus fréquent du sein provoquant une douleur constante au sein. Le seul traitement connu dans la médecine conventionnelle consiste à prescrire les médicaments anti-infl ammatoires qui donnent un soulagement temporaire ou une excision chirurgicale qui entraîne la cicatrisation du tissu mammaire. La littérature homéopathique montre que les cas liés aux masses dans le sein, la mastite, etc. ont été traités avec succès ; cependant, aucune étude de cas/essai de recherche n'a été documenté jusqu'à ce jour dans une publication approuvée par des collègues. Le cas signalé ici concerne la fi broadénose chez une femme âgée de 31 ans qui a été traitée avec succès par des médicaments homéopathiques personnalisés dans les 6 mois suivant la manifestation de la maladie sans récurrence de celle-ci. La Phytolacca a été prescrite comme remède constitutionnel sur la base de l'ensemble des symptômes et après la répertorisation. Les procédures d'investigation telles que la mammographie et l'échographie ont été effectuées avant et après la prise de médicaments pour constater la résolution des kystes. La patiente a été observée pendant plus d'un an sans que la maladie ne se remanifeste, ce qui peut être considéré comme un traitement quasi-permanent par le biais d'un traitement homéopathique personnalisé. Ce cas illustre que l'homéopathie peut être une meilleure option thérapeutique pour de telles conditions chirurgicales.
順勢療法緩解的纖維腺病變之病例報告 順勢療法緩解的纖維腺病變之病例報告 摘要 摘要 纖維腺病變又稱乳房纖維囊腫，是引起持續性乳房疼痛最常見的乳房良性疾病。常規藥物中唯一已知的 纖維腺病變又稱乳房纖維囊腫，是引起持續性乳房疼痛最常見的乳房良性疾病。常規藥物中唯一已知的 治療方法是抗炎藥物，這種藥物只可臨時緩解，或以手術切除，但會使乳房組織結疤。順勢療法文獻顯 治療方法是抗炎藥物，這種藥物只可臨時緩解，或以手術切除，但會使乳房組織結疤。順勢療法文獻顯 示，有成功治療乳房腫塊、乳腺炎……等等的個案，但直至現在均沒有案例分析／研究試驗於同行評審 示，有成功治療乳房腫塊、乳腺炎……等等的個案，但直至現在均沒有案例分析／研究試驗於同行評審 中被記錄。這裡有一個成功個案，一名31歲患有纖維腺病變的女性被成功治癒，她在接受個人化順勢療 中被記錄。這裡有一個成功個案，一名31歲患有纖維腺病變的女性被成功治癒，她在接受個人化順勢療 法藥物治療後的6個月內也沒有復發。根據她的整體症狀和療劑彙集分析對照後，處方了體質療劑商陸 法藥物治療後的6個月內也沒有復發。根據她的整體症狀和療劑彙集分析對照後，處方了體質療劑商陸 (Phytolacca)。在研究過程的前後，會進行乳房攝影術&超音波檢查 (USG)，以記錄囊腫的消失。已經觀察 (Phytolacca)。在研究過程的前後，會進行乳房攝影術&超音波檢查 (USG)，以記錄囊腫的消失。已經觀察 病人超過1年以上都沒有復發，因此可被認為這是被順勢療法個人化治療至接近永久性治癒。這個個案可 病人超過1年以上都沒有復發，因此可被認為這是被順勢療法個人化治療至接近永久性治癒。這個個案可 顯示，對於這種外科疾病順勢療法可能是更好的治療選擇。 顯示，對於這種外科疾病順勢療法可能是更好的治療選擇。
